Englebert Financial Advisers, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2097035 Allentown, PA

Position in VRTX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$212,600

+$7,228 QoQ

Shares Held

428

-5.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

#1,396

of 1,735 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Englebert Financial Advisers, LLC holds $1,106,212 across 3 Biotechnology names. VRTX ranks #3 (19.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	11,699	$456,377
2	PRAX	Praxis Precision Medicines, Inc.	1,306	$437,235
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	428	$212,600

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,600	428	-5.5%	Shares	Sole	2026-07-22
2025-12-31	$205,372	453	—	Shares	Sole	2026-02-04
No filing history on record for this holder in this stock.